Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray H Passo

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pediatric Nephrology (Berlin, Germany)|January 19, 2008
Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritisMichiko Suzuki, Kristina M Wiers, Marisa S Klein-Gitelman, et al.
Arthritis and Rheumatism|August 29, 2009
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activityClaas H Hinze, Michiko Suzuki, Marisa Klein-Gitelman, et al.
Arthritis and Rheumatism|March 1, 2007
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisJack Bleesing, Anne Prada, David M Siegel, et al.
Clinical Chemistry|September 27, 2002
Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathiesLisa G Rider, Adam S Schiffenbauer, Mark Zito, et al.
Arthritis Care & Research|September 16, 2010
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritisDaniel J Lovell, Murray H Passo, Timothy Beukelman, et al.
Arthritis and Rheumatism|November 24, 2011
Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trialSusmita Kashikar-Zuck, Tracy V Ting, Lesley M Arnold, et al.
Arthritis Care & Research|November 10, 2012
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritisYukiko Kimura, Jennifer E Weiss, Kathryn L Haroldson, et al.
Arthritis and Rheumatism|February 2, 2008
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositisAdam M Huber, Elizabeth M Dugan, Peter A Lachenbruch, et al.
Arthritis and Rheumatism|May 18, 2004
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Brian M Feldman, Robert M Rennebohm, et al.
Arthritis and Rheumatism|June 10, 2004
Normal scores for nine maneuvers of the Childhood Myositis Assessment ScaleRobert M Rennebohm, Karla Jones, Adam M Huber, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pediatric Nephrology (Berlin, Germany)|January 19, 2008
Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritisMichiko Suzuki, Kristina M Wiers, Marisa S Klein-Gitelman, et al.
Arthritis and Rheumatism|August 29, 2009
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activityClaas H Hinze, Michiko Suzuki, Marisa Klein-Gitelman, et al.
Arthritis and Rheumatism|March 1, 2007
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisJack Bleesing, Anne Prada, David M Siegel, et al.
Clinical Chemistry|September 27, 2002
Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathiesLisa G Rider, Adam S Schiffenbauer, Mark Zito, et al.
Arthritis Care & Research|September 16, 2010
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritisDaniel J Lovell, Murray H Passo, Timothy Beukelman, et al.
Arthritis and Rheumatism|November 24, 2011
Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trialSusmita Kashikar-Zuck, Tracy V Ting, Lesley M Arnold, et al.
Arthritis Care & Research|November 10, 2012
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritisYukiko Kimura, Jennifer E Weiss, Kathryn L Haroldson, et al.
Arthritis and Rheumatism|February 2, 2008
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositisAdam M Huber, Elizabeth M Dugan, Peter A Lachenbruch, et al.
Arthritis and Rheumatism|May 18, 2004
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Brian M Feldman, Robert M Rennebohm, et al.
Arthritis and Rheumatism|June 10, 2004
Normal scores for nine maneuvers of the Childhood Myositis Assessment ScaleRobert M Rennebohm, Karla Jones, Adam M Huber, et al.
Pageof 4